Clinical trial
Investigation of the Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
NCT07431658 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
- Lead sponsor
- Istanbul Training and Research Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- December 1, 2025
- Completion date
- March 31, 2027
- Enrollment
- 116 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic spontaneous urticaria (csu)